|
|
|
18.11.25 - 08:48
|
Mit diesen 3 Aktien sicherst du dir fast 5 % Dividende (Aktienwelt360)
|
|
|
Drei Aktien mit hohen Dividenden: Altria, Arca Continental und Pfizer kombinieren robuste Geschäftsmodelle, attraktive Renditen und bieten klar definierte Chancen.
Der Artikel Mit diesen 3 Aktien sicherst du dir fast 5 % Dividende ist zuerst erschienen auf Aktienwelt360....
|
|
|
|
|
|
|
|
|
|
|
|
|
20.08.25 - 14:36
|
Santhera signs deal with Uniphar for GCC distribution of Agamree (PBR)
|
|
|
The therapy is intended for the treatment of Duchenne muscular dystrophy (DMD) in patients aged four years and above. Sales are projected to begin on a named patient
The post Santhera signs deal with Uniphar for GCC distribution of Agamree appeared first on Pharmaceutical Business review....
|
|
|
|
|
|
|
|
|
|
|
24.06.25 - 00:45
|
GENOMMA LAB INTERNACIONAL ANNOUNCES TWELFTH DIVIDEND PAYMENT (PR Newswire)
|
|
|
MEXICO CITY, June 23, 2025 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company"), one of the leading pharmaceutical and personal care product companies in Mexico with an expanding international presence, informs that the Company filed a......
|
|
|
|
|
|
|
|
|
20.04.25 - 17:30
|
In The Holiday Shortened Easter Week, These Large-Cap Stock Were Top Performers (Apr 14-Apr 18): Are These In Your Portfolio? (Benzinga)
|
|
|
Top performers last week: ServiceTitan, Summit Therapeutics, YPF, Eli Lilly, MicroStrategy, America Movil, Ericsson, Insmed, Diamondback, Neurocrine Biosciences.
read more...
|
|
|
11.04.25 - 10:18
|
OncoZenge enters licensing agreement with Avernus Pharma for BupiZenge™ in the GCC Region (Cision)
|
|
|
OncoZenge AB (publ) [”OncoZenge” or the "Company”] announces that the Company and Avernus Pharma General Trading LLC (“Avernus”), a pharma marketing company from the UAE, have signed an exclusive agreement to license BupiZenge™ (Bupivacaine oral lozenges) for commercialization and distribution in the Gulf Cooperation Council (GCC) region.
Background
The licensing agreement entails that Avernus will be the exclusive distributor of BupiZenge™ in the GCC region, including Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and the UAE, pending successful completion of the BupiZenge™ phase 3 trial and...
|
|
|
|
|
11.03.25 - 16:18
|
EQL Pharma signs a distribution agreement with a large distributor in the GCC countries for Mellozzan (melatonin) (Cision)
|
|
|
EQL has entered into an exclusive distribution agreement with Pharmalink for its product Mellozzan (melatonin) for the GCC (Gulf Cooperation Council) region comprising of United Arab Emirates, Saudi Arabia, Kuwait, Qatar, Oman and Bahrain. "EQL has previously signed many agreements with parties for EU territories, but this is a milestone as it is our first agreement with the sale of one of our products outside the borders of Europe," says Axel Schörling, CEO at EQL Pharma.
Mellozzan contains the sleep hormone melatonin and is indicated for children who have ADHD and suffer from sleep...
|
|
|
06.03.25 - 22:48
|
GENOMMA LAB INTERNACIONAL ANNOUNCES ELEVENTH DIVIDEND PAYMENT (PR Newswire)
|
|
|
MEXICO CITY, March 6, 2025 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company"), one of the leading pharmaceutical and personal care product companies in Mexico with an expanding international presence, informs that the Company filed a......
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
